Adipose MSCs Suppress MCF7 and MDA-MB-231 Breast Cancer Metastasis and EMT Pathways Leading to Dormancy via

Norlaily Mohd Ali1, Swee Keong Yeap2, Wan Yong Ho3

  • 1Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Cheras 43000, Malaysia.

Insights

Adipose mesenchymal stem cells (MSCs) induce breast cancer cell dormancy via exosomal microRNAs, inhibiting metastasis and promoting chemoresistance. This discovery offers potential biomarkers for predicting relapse and new therapeutic targets.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Breast cancer relapse is a major challenge, often linked to dormant cancer cells surviving treatment.
  • The tumor microenvironment (TME) influences cancer cell dormancy and epithelial-to-mesenchymal transition (EMT), impacting patient mortality.
  • Mesenchymal stem cells (MSCs) interact with cancer cells in the TME through secreted exosomes containing microRNAs (miRNAs).

Purpose of the Study:

  • To investigate the role of adipose MSCs in inducing dormancy in breast cancer cells (BCCs) via exosomal miRNAs.
  • To understand how MSC-derived exosomal miRNAs modulate signaling pathways, cell cycle arrest, and EMT.
  • To identify potential miRNA markers for predicting breast cancer metastasis and relapse.

Main Methods:

  • Indirect co-culture of MCF7 (luminal) and MDA-MB-231 (basal) breast cancer cells with adipose MSCs.
  • Harvesting exosomes from the co-culture medium.
  • Analyzing exosomal miRNA profiles and their impact on BCC phenotypes, including dormancy, metastasis, and EMT.

Main Results:

  • MSC-derived exosomes induced distinct miRNA profiles in BCCs.
  • These exosomal miRNAs modulated signaling pathways, leading to cell cycle arrest and dormancy.
  • Breast cancer cells exhibited a shift towards a dormant-epithelial phenotype, with reduced metastasis and increased chemoresistance.

Conclusions:

  • Adipose MSCs play a critical role in inducing breast cancer cell dormancy through exosomal miRNAs.
  • Identified miRNAs are potential biomarkers for predicting metastatic patterns and cancer relapse.
  • These miRNAs represent promising therapeutic targets for novel breast cancer treatments.